Influence of the Vitamine E Coated Dialyzer on Inflammation and Anemia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-10-16

Study Completion Date

2018-12-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the effect of a vitamin E coated high flux polysulfone dialyzer on the inflammatory state of patients' end stage renal disease and its clinical benefits in terms of anemia Objectives : To assess the benefits of a vitamin E coated polysulfone membrane on the micro-inflammatory state of chronic dialysis patients Prospective multicenter controlled and randomized study Number of patients : 120 patients (60 patients per group)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Vitamin E-coated Polysulfone Membrane on Oxidative Stress, Inflammation and Monocytes in Critically Ill Patients in CRRT

NCT03489759

Renal Failure Renal Insufficiency, Acute

UNKNOWN NA

Comparison of the Removal of Uremic Toxins With Medium Cut-off and Super High-flux Vitamin E-coated Dialyzers

NCT05610683

End Stage Renal Disease (ESRD)

COMPLETED NA

Evaluation of Biocompatibility and Performances of 4 Dialyzers in Different Mode Treatments

NCT03262272

End Stage Renal Disease Inflammation

COMPLETED NA

Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients

NCT03083184

Tunnelled Hemodialysis Catheter Infection

RECRUITING PHASE3

Dialysis Performance of Different Dialyzer Membranes Using Different Coagulation Strategies

NCT03820401

Hemodialysis Coagulation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Coordinator : Pr JP.CRISTOL Montpellier hospital university Rational : The hemodialyzed patients are subject to inflammation due to their pathologies and to the technique. The VIE dialyzer polysulfon coated to vitamin E has been shown to have a favourable action on inflammation and anemia. The investigators want to highlight the influence of vitamine E graft using as controlled dialyzer a similar polysulfon from the same manufacturer without vitamin E.

Medical device : ViE High flux dialyzer -\> vitamin E coated polysulfone membrane manufactured by Asahi Kasei Medical, with CE mark and intended for use in hemodialysis for the patient suffering from acute or chronic renal failure Controlled medical device : Leoceed H high flux dialyzer : polysulfone membrane manufactured by Asahi Kasei Medical, with CE mark and intended for use in hemodialysis for patient suffering from acute or chronic renal failure Objectives : To assess the benefits of a vitamin E coated polysulfone membrane on the micro-inflammatory state of chronic dialysis patients Primary end point : Evolution of the well-known inflammatory marker : High sensibility-CRP Secondary end point : Evolution of the following inflammatory markers : IL-6, TNFa, fibrinogen, antibodies anti- LDLox Evolution of Hemoglobin and ERI Evolution of Nutritional parameters : albumin and pre albumin Study design : Prospective multicenter controlled and randomized protocol study Duration : 12 months Number of patients : 120 patients : 60 patients per group 120 patients : 60 patients per group Adult ESRD patient, whatever the origin, treated by HD, thrice a week for about 4 hours and hemo dynamically well balanced Inclusion criteria : Dialyzed patient on synthetic high flux dialyzer for 3 months Patient with a vascular access allowing a blood flow rate ≥ 250 ml/min Patient with micro inflammation, i.e an average CRP between 5 and 20 mg/L on the two last check-up of CRP Patient informed of the study and having signed the inform consent. Exclusion criteria : Underage patient Subjects who are pregnant or planning to become pregnant during the study Patient with an infection influencing the Hb level

Patient with an Iron deficiency showed with :

Transferin saturation \< 20 % and/or Ferritin \< 100 µg/L, Hemo transfusion in the last two months Patient treated by HF, HDF, biofiltration Patient with infectious risks Subjects who participated in a clinical study involving dialyzers in the last two months

Criteria of exit :

Patient wish Medical decision Hemo transfusion Departure for another dialysis center Transplantation Death

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Disease Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Prospective multicenter controlled and randomized protocol study

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ViE High flux dialyzer

vitamin E coated polysulfone membrane manufactured by Asahi Kasei Medical, with CE mark and intended for use in hemodialysis for the patient suffering from acute or chronic renal failure

Group Type EXPERIMENTAL

VIE high flux dialyzer

Intervention Type DEVICE

Asssesment of the therapeutic effect of the vitamin E coating

Leoceed H high flux dialyzer

polysulfone membrane manufactured by Asahi Kasei Medical, with CE mark and intended for use in hemodialysis for patient suffering from acute or chronic renal failure

Group Type ACTIVE_COMPARATOR

Leoceed H high flux dialyzer

Intervention Type DEVICE

Use of the Leoceed H dialyzer during one year per patient enrolled in the control group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VIE high flux dialyzer

Asssesment of the therapeutic effect of the vitamin E coating

Intervention Type DEVICE

Leoceed H high flux dialyzer

Use of the Leoceed H dialyzer during one year per patient enrolled in the control group

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult ESRD patient, whatever the origin, treated by HD, thrice a week for about 4 hours and hemo dynamically well balanced
* Dialyzed patient on synthetic high flux dialyzer for 3 months
* Patient with a vascular access allowing a blood flow rate ≥ 250 ml/min
* Patient with micro inflammation, i.e an average CRP between 5 and 20 mg/L on the two last check-up of CRP
* Patient informed of the study and having signed the inform consent.

Exclusion Criteria

* Underage patient
* Subjects who are pregnant or planning to become pregnant during the study
* Patient with an infection influencing the Hb level
* Patient with an Iron deficiency showed with :

Transferin saturation \< 20 % and/or Ferritin \< 100 µg/L,

* Patients having received an Hemo transfusion in the last two months
* Patient treated by HF, HDF, biofiltration
* Patient with infectious risks
* Subjects who participated in a clinical study involving dialyzers in the last two months

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No